Olympus Unveils Revolutionary AI Surgical Planning Tool in Partnership with Ziosoft

Olympus Launches Advanced AI-Powered Surgical Planning Tool

Olympus Corporation, a leader in medical technology, has made a groundbreaking announcement with the launch of its first AI-driven clinical decision tool, developed through a strategic alliance with Ziosoft, a leading software company specializing in advanced imaging solutions. The innovative tool is set to reshape surgical procedures related to liver, lung, and kidney operations, enhancing pre-operative planning for surgeons and improving patient outcomes.

This new application leverages cutting-edge imaging analytics and machine learning technologies. By enabling surgeons to visualize complex anatomical structures in three dimensions, the tool significantly enhances their ability to plan and execute surgeries while minimizing invasive approaches. As a staple in the medical technology field, Olympus aims to streamline clinical workflows and improve patient care through its commitment to innovation.

The Applications of the AI Tool

The AI-powered platform will focus on three primary applications:

1. Thoracic Surgery: This approach transforms traditional 2D CT and MRI images into precise 3D models, allowing for improved planning of lung cancer surgeries and thoracic procedures. The goal is to reduce the invasiveness of such procedures while ensuring accuracy in targeting cancerous tissues.

2. Liver Surgery: Leveraging this tool, surgeons can visualize liver anatomy in detail. By mapping out vessels and tumors before the operation, they can plan liver-sparing surgeries more effectively—an essential factor in enhancing patient recovery rates.

3. Urologic Surgery: This application aids in minimally invasive nephrectomies by accurately assessing tumors, cysts, and other anatomical abnormalities. Improved visualization helps surgeons make informed decisions during surgery, further enhancing patient outcomes.

A Step Forward in Surgical Innovation

Darryl Rock, Vice President and Business Unit Leader of Surgical Solutions at Olympus, emphasizes that this collaboration with Ziosoft aligns with the company's mission to integrate AI-driven solutions into healthcare. Rock states, "This collaboration represents a significant step forward in Olympus's mission to bring innovative, AI-enabled solutions to the healthcare industry."

Traditionally, physicians have relied on flat, two-dimensional images to plan surgical procedures, but this innovative AI application harnesses the power of advanced imaging techniques, translating static images into dynamic, real-time 3D models. This resource allows physicians to make more informed clinical decisions, assisting in the preservation of as much healthy tissue as possible and improving tumor margin assessments.

Importantly, the development of detailed 3D modeling can also serve as a valuable educational tool for surgical fellows and guide newer surgeons through complex procedures. By incorporating AI-powered clinical decision support applications, Olympus underscores its commitment to improving surgical outcomes while revolutionizing the healthcare landscape.

Rajeev Taitriya, Vice President of Business Development and Marketing at Ziosoft, echoed the significance of this partnership, stating, "Ziosoft is committed to improving patient outcomes, and we are pleased to collaborate with Olympus to equip clinicians with greater diagnostic capabilities through advanced visualization."

Feature at SAGES Annual Meeting

Olympus will prominently feature the Ziosoft Revoras platform at the upcoming annual meeting of the Society of Gastrointestinal and Endoscopic Surgeons (SAGES) from March 12-15 in Long Beach, California. The annual gathering will showcase Olympus's comprehensive surgical portfolio, including systems designed to enhance visualization and procedural accuracy across various specialties.

Additionally, Olympus plans to highlight its multispecialty imaging platform alongside the ESG-410™ Surgical Energy Platform, which provides a holistic energy solution that caters to numerous surgical disciplines, including general, thoracic, urology, and gynecology. The company will also present its EVIS X1™ Endoscopy System, the pioneering cloud-based AI endoscopic system aimed at aiding gastroenterologists and colorectal surgeons in diligently detecting and localizing suspected colorectal polyps during procedures.

Olympus's CADDIE™ AI System will analyze endoscopic video of the colon in real-time, offering visual markers to alert endoscopists about potential polyp presence. The final assessment, however, remains in the hands of medical professionals, ensuring rigorous diagnostic processes are upheld.

For more insights into the innovative surgical portfolio of Olympus and to experience the advancements in AI-driven healthcare tools, attendees are encouraged to visit Olympus's booth, #749, at the SAGES conference or explore their offerings on the Olympus website.

About Olympus Corporation

Olympus is dedicated to enhancing the health and well-being of individuals through its cutting-edge medical technology solutions. With over a century of experience, the company continually strives to make significant contributions to society through impactful products and services designed for optimal patient outcomes. Headquartered in Center Valley, Pennsylvania, Olympus employs over 4,500 professionals across North and South America.

About Ziosoft

Since its establishment in 1998, Ziosoft has emerged as a pioneer in 3D visualization and analysis software for functional CT/MRI, significantly improving diagnostic confidence and treatment planning precision for healthcare providers worldwide. With thousands of systems installed globally and an impressive publication record, Ziosoft remains at the forefront of advanced visualization technologies that prioritize patient care.